Plain-English translation of NCT07721597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage research trial testing a new medication called ZP6590 that may help with weight management. Researchers want to understand how safe this medication is, how your body processes it, and whether it causes any side effects. You would receive either the actual medication or a placebo (inactive injection) and be closely monitored.
Obesity and weight management are significant health challenges, and researchers are working to develop new treatment options. This trial is the first time this medication is being tested in humans, so scientists need to carefully study its safety and how it works in the body before it can be considered for wider use.
You likely qualify if…
You likely don't qualify if…
The trial has two parts. In the first part, you would receive a single injection and be monitored for 4 weeks. In the second part, you would receive multiple injections over 6 to 12 weeks, followed by 6 weeks of follow-up observation. You'll have clinic visits where staff will check your vital signs, draw blood, and ask how you're feeling to make sure the medication is safe.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Germany